How to Know if You Need Drug or Alcohol Rehab: Addiction Assessment, Diagnosis, and Early Detection

You may need drug or alcohol rehab when substance use is difficult to control, causes repeated harm, or creates safety, intoxication, or withdrawal concerns. Early detection recognizes the pattern, screening estimates risk, and clinical assessment determines diagnosis and level of care. Online information cannot diagnose a substance use disorder, and a person does not need to wait for a crisis to request an assessment.

What signs suggest that rehab may be appropriate?

Rehab may be appropriate when substance use repeatedly affects control, responsibilities, relationships, safety, or physical functioning. The pattern matters more than one isolated event, and a person may need an assessment even when they are still working, attending school, or maintaining some responsibilities.

Early warning signs of addiction include behavioral, physical, psychological, and social changes. When those changes persist or cause harm, screening can identify risk, assessment can determine whether diagnostic criteria are met, and treatment planning can match the level of care.

Functional and clinical signals that warrant a professional substance-use assessment

Signal	What it may look like	Why assessment helps
Impaired control	Using more than intended, spending substantial time obtaining or recovering from use, or making repeated unsuccessful attempts to cut back	A clinician can clarify pattern, severity, triggers, and treatment goals
Social or role impairment	Missed work, school, caregiving, obligations, or important activities; recurring conflict connected to use	Assessment connects substance use with daily functioning without reducing the person to a label
Risky use	Using while driving, combining substances, using in unsafe settings, or continuing after a serious health warning	Safety planning can address immediate risk and identify the right treatment intensity
Tolerance or withdrawal	Needing more for a similar effect or experiencing physical or psychological symptoms after reducing or stopping	Medical guidance can reduce withdrawal and overdose risks that make unsupervised stopping unsafe

What does early detection mean in addiction?

Early detection means recognizing a concerning pattern before substance use produces a medical emergency, severe functional loss, or repeated crisis. A change in control, consequences, risk, tolerance, withdrawal, mood, or daily functioning can prompt screening even when the person does not appear visibly impaired.

Drug and alcohol screening tests compare patterns of use and related consequences through structured questions. They help identify who needs a fuller evaluation; they do not prove that a disorder exists or select a rehabilitation setting on their own.

Early detection moves from an observed change to a clinical treatment decision

Step	Question answered	What the result can support
Recognition	Has control, safety, health, mood, or functioning changed?	A timely conversation or routine screening
Screening	Does a validated questionnaire indicate elevated substance-use risk?	Brief intervention or referral for assessment
Diagnostic assessment	Are substance-specific diagnostic criteria met, and what else could explain the symptoms?	A diagnosis, severity rating, or alternative explanation
Level-of-care assessment	Which setting can safely address withdrawal, health, psychiatric, environmental, and access needs?	An individualized treatment recommendation

How are screening, drug testing, assessment, and diagnosis different?

Screening estimates risk, biological testing detects selected substances or metabolites, assessment gathers clinical context, and diagnosis applies formal criteria. These processes can inform one another, but they answer different questions and should not be treated as interchangeable evidence.

Different addiction evaluation methods and the limits of each result

Method	Primary question	What it cannot establish alone
Questionnaire screening	Is the reported pattern concerning enough for intervention or further assessment?	A substance use disorder diagnosis or treatment placement
Biological drug or alcohol testing	Was a target substance, metabolite, or alcohol concentration detected within the test's limits?	Loss of control, impairment over time, prescribed intent, or addiction
Clinical assessment	What substances, symptoms, risks, health conditions, supports, and barriers affect care?	A guaranteed outcome or one permanent level of care
Diagnosis	Does the full pattern meet substance-specific diagnostic criteria, and how severe is it?	The safest treatment setting without a separate needs assessment

Oral-fluid drug testing addresses recent biological exposure, specimen collection, detection windows, and assay limitations. A positive or negative result must be interpreted with timing, prescribed medications, the test panel, confirmation methods, and the clinical history.

Alcohol screening tests use questions about drinking frequency, quantity, control, and consequences to identify risk. Breath alcohol measurement answers a different question about alcohol concentration at a particular time.

How is a substance use disorder diagnosed?

A qualified clinician diagnoses a substance use disorder by applying substance-specific criteria to symptoms occurring within a defined period and confirming clinically significant impairment or distress. For alcohol use disorder, the DSM-5-TR counts 11 possible symptoms within 12 months: 2 to 3 indicate mild AUD, 4 to 5 moderate AUD, and 6 or more severe AUD. Drug-related diagnoses use the criteria for the applicable substance class rather than a generic test score.

The evaluation groups evidence around impaired control, social impairment, risky use, and pharmacological effects while also considering timing, prescriptions, medical illness, sleep loss, pain, trauma, anxiety, depression, mania, psychosis, and cognitive change. Tolerance or withdrawal during appropriate medical treatment does not automatically establish a substance use disorder.

A drug and alcohol addiction assessment combines the diagnostic interview with substance-use history, withdrawal and overdose history, medical and psychiatric needs, medications, functioning, supports, and barriers to care. The result may be a diagnosis, a recommendation for monitoring or brief intervention, or a referral to treatment.

What does a substance-use screening do?

A substance-use screen is a brief risk check, not a diagnosis and not a treatment-placement decision by itself. SAMHSA describes SBIRT as screening, brief intervention, and referral to treatment; a positive screen leads to further assessment when the person may need specialty care.

Questions to bring to a screening or intake

• What substance or combination of substances is being used, and how often?
• When was the last use, and have tolerance or withdrawal symptoms changed?
• Has use affected work, school, caregiving, finances, relationships, health, or legal obligations?
• Have there been overdoses, blackouts, seizures, injuries, unsafe driving, or mixing of substances?
• What happened during previous attempts to stop or cut down?
• Are anxiety, depression, trauma symptoms, psychosis, suicidal thoughts, or medication concerns also present?

SBIRT combines screening, a brief intervention, and referral to treatment. Screening identifies risk, the brief intervention addresses the pattern, and referral connects a person to assessment or treatment when indicated.

When is substance use an emergency?

Call 911 for an unresponsive person, slow or difficult breathing, suspected overdose, seizure, severe confusion, active suicidal intent, or another immediate threat to life. CDC guidance says to give naloxone when an opioid overdose is possible and naloxone is available, call 911, support breathing, place the person on their side when appropriate, and stay until emergency help arrives.

How do withdrawal and tolerance affect the decision?

Tolerance changes the amount needed for an effect, withdrawal follows reduction or stopping, and both can increase the need for medical assessment. Tolerance does not prove addiction, and withdrawal does not determine one universal treatment setting. The substance, dose, duration, co-use, health history, prior withdrawal, and current symptoms all change the safety picture.

A person with a history of severe alcohol or sedative withdrawal, seizures, delirium, or serious medical complications should ask a clinician about withdrawal management before stopping. Opioid withdrawal is also clinically important, but its risks, medications, and monitoring needs differ from alcohol or benzodiazepine withdrawal.

How does a clinician decide which level of care fits?

Clinicians match level of care to multidimensional risk and need rather than to a diagnosis or symptom count alone. The ASAM Criteria Fourth Edition assesses intoxication, withdrawal, and addiction-medication needs; biomedical conditions; psychiatric and cognitive conditions; substance-use-related risks; recovery-environment interactions; and person-centered considerations such as barriers, preferences, and motivational needs.

Common treatment settings and the needs they are designed to address

Setting	Typical purpose	What changes the recommendation
Outpatient	Scheduled counseling, medication management, monitoring, and recovery support while living at home	Stable symptoms, manageable withdrawal risk, safe housing, and reliable attendance
Intensive outpatient or partial care	More frequent daytime or evening clinical structure without overnight residence	Need for closer monitoring or repeated skill practice without continuous residential support
Residential treatment	Structured living and treatment when the home environment or relapse risk makes outpatient care unsafe or ineffective	Need for a protected setting, continuous support, or separation from active triggers
Medically managed care	Medical stabilization or withdrawal management for acute health and safety needs	Severe withdrawal, medical instability, overdose risk, or another condition requiring medical monitoring

Placement is revisited as symptoms, substance use, safety, attendance, supports, and goals change. Outpatient treatment options range from periodic clinical visits to intensive schedules on several days each week; assessment determines whether that structure is sufficient or a higher level of care is needed.

How can mental health symptoms change the treatment assessment?

Co-occurring mental health symptoms can change safety planning, diagnosis, medication decisions, and the level of support needed. Anxiety, depression, trauma symptoms, psychosis, mania, and substance-induced symptoms may overlap, so a clinician should assess timing, severity, substance exposure, and immediate risk rather than assume one cause.

Urgent psychiatric symptoms require crisis evaluation; stable co-occurring needs require integrated care. When substance use and persistent psychiatric symptoms affect the same treatment decision, outpatient mental-health treatment can coordinate therapy, psychiatric evaluation, and medication management while the person remains stable between sessions.

What should someone do if they are unsure?

Start with a confidential screening or clinical assessment, describe the actual pattern of use, and ask what level of care is safest. Bring a medication list, recent substance-use history, withdrawal history, medical conditions, mental-health symptoms, and practical barriers such as transportation or caregiving. A person does not need to promise lifelong abstinence or meet a crisis threshold before requesting an evaluation.

For a loved one, describe specific observations, choose a private time, ask open questions, and offer help with an assessment. Avoid diagnosing, threatening, or forcing a conversation while the person is intoxicated unless there is an immediate safety emergency.